Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-6213 PET Imaging in Solid Tumors
NCT07070349Phase 2Recruiting
- Sponsor
- Hengrui
- Start
- Jul 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-6213 in solid tumor, sponsored by Hengrui. Started Jul 2025; status: recruiting.
02
Drugs
HRS-6213
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07070349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07070349.